Skip to content
healthcare.dev

eribulin mesylate

NDC 68083-592, eribulin mesylate, injection, from Gland Pharma Limited.

Product NDC
68083-592
Status
Listed
Labeler
Gland Pharma Limited
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218047
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68083-592 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
68083-592-01680830592011 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f57835e2-4c53-4e93-b54b-7d7a5000ae3d

Use it

Look up 68083-592 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68083-592 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68083-592. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.